XML 54 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation And Employee Benefit Plans (Tables)
12 Months Ended
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Assumptions Used In The Black-Scholes Valuation Model
 
 
ESPP Purchase Rights
 
 
Year Ended March 31,
 
 
2018
 
2017
 
2016
Risk-free interest rate
 
1.1 - 2.0%

 
0.5 - 0.8%

 
0.3 - 0.6%

Expected volatility
 
28 - 30%

 
25 - 32%

 
32 - 36%

Weighted-average volatility
 
29
%
 
27
%
 
33
%
Expected term
 
6 - 12 months

 
6 - 12 months

 
6 - 12 months

Expected dividends
 
None

 
None

 
None

Schedule Of Assumptions Used In Monte-Carlo Simulation Model
The assumptions used in the Monte-Carlo simulation model to value our market-based restricted stock units were as follows: 
 
Year Ended March 31,
 
2018
 
2017
 
2016
Risk-free interest rate
1.5 - 1.6%

 
0.8
%
 
1.0
%
Expected volatility
17 - 46%

 
16 - 57%

 
14 - 53%

Weighted-average volatility
28
%
 
29
%
 
26
%
Expected dividends
None

 
None

 
None

Schedule Of Stock-Based Compensation Expense By Statement Of Operations
The following table summarizes stock-based compensation expense resulting from stock options, restricted stock units, market-based restricted stock units, performance-based restricted stock units, and the ESPP purchase rights included in our Consolidated Statements of Operations (in millions):
 
 
Year Ended March 31,
 
 
2018
 
2017
 
2016
Cost of revenue
 
$
3

 
$
3

 
$
2

Research and development
 
146

 
109

 
103

Marketing and sales
 
32

 
31

 
24

General and administrative
 
61

 
53

 
49

Stock-based compensation expense
 
$
242

 
$
196

 
$
178

Summary Of Outstanding And Exercisable Stock Options
The following table summarizes outstanding and exercisable stock options as of March 31, 2018: 
 
 
Options Outstanding
 
Options Exercisable
Range of
Exercise Prices
 
Number
of Shares
(in thousands)
 
Weighted-
Average
Remaining
Contractual
Term  (in years)
 
Weighted-
Average
Exercise
Prices
 
Potential
Dilution
 
Number
of Shares
(in thousands)
 
Weighted-
Average
Exercise
Prices
 
Potential
Dilution
$11.53 - $22.42
 
119

 
1.41
 
$
19.80

 
%
 
119

 
$
19.80

 
0.1
%
26.25 - 26.25
 
750

 
5.59
 
26.25

 
0.3
%
 
750

 
26.25

 
0.2
%
33.60 - 47.06
 
746

 
5.94
 
36.01

 
0.2
%
 
746

 
36.01

 
0.2
%
$11.53 - $47.06
 
1,615

 
5.44
 
$
30.28

 
0.5
%
 
1,615

 
$
30.28

 
0.5
%
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]
The following table summarizes our ESPP activity for fiscal years ended March 31, 2018, 2017 and 2016: 
 
 
Shares Issued
(in millions)
 
Exercise Prices for Purchase Rights
 
Weighted-Average Fair Values of Purchase Rights
Fiscal Year 2016
 
0.9

 
$32.16 - $54.78
 
$
12.97

Fiscal Year 2017
 
0.7

 
$54.60 - $67.56
 
$
17.93

Fiscal Year 2018
 
0.6

 
$67.56 - $99.82
 
$
21.57

Shares Repurchased and Retired

The following table summarizes total shares repurchased during fiscal years 2018, 2017, and 2016:
 
May 2014 Program
 
May 2015 Program
 
February 2016 Program
 
May 2017 Program
 
Total
(In millions)
Shares
 
Amount
 
Shares
 
Amount
 
Shares
 
Amount
 
Shares
 
Amount
 
Shares
 
Amount
Fiscal Year 2016
1.0

 
$
57

 
6.9

 
$
461

 
7.8

 
$
500

 

 
$

 
15.7

 
$
1,018

Fiscal Year 2017

 
$

 
6.5

 
$
508

 

 
$

 

 
$

 
6.5

 
$
508

Fiscal Year 2018

 
$

 
0.3

 
$
31

 

 
$

 
5.0

 
$
570

 
5.3

 
$
601

Employee Stock Option [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
The following table summarizes our stock option activity for the fiscal year ended March 31, 2018: 
 
 
Options
(in thousands)
 
Weighted-
Average
Exercise Prices
 
Weighted-
Average
Remaining
Contractual
Term  (in years)
 
Aggregate
Intrinsic Value
(in millions)
Outstanding as of March 31, 2017
 
2,377

 
$
33.35

 
 
 
 
Granted
 
5

 
113.39

 
 
 
 
Exercised
 
(764
)
 
40.30

 
 
 
 
Forfeited, cancelled or expired
 
(3
)
 
41.71

 
 
 
 
Outstanding as of March 31, 2018
 
1,615

 
$
30.28

 
5.44
 
$
147

Vested and expected to vest
 
1,615

 
$
30.28

 
5.44
 
$
147

Exercisable as of March 31, 2018
 
1,615

 
$
30.28

 
5.44
 
$
147

Restricted Stock Rights [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
Each restricted stock unit granted reduces the number of shares available for grant by 1.43 shares under our Equity Plan. The following table summarizes our restricted stock units activity, excluding market-based restricted stock unit activity which is discussed below, for the fiscal year ended March 31, 2018: 
 
 
Restricted
Stock Units
(in thousands)
 
Weighted-
Average Grant
Date Fair Values
Outstanding as of March 31, 2017
 
5,153

 
$
65.03

Granted
 
3,841

 
110.05

Vested
 
(2,581
)
 
59.49

Forfeited or cancelled
 
(465
)
 
80.97

Outstanding as of March 31, 2018
 
5,948

 
$
94.57


Performance Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
 
Performance-
Based Restricted
Stock Units
(in thousands)
 
Weighted-
Average Grant
Date Fair Value
Outstanding as of March 31, 2017

 
$

Granted
796

 
110.51

Forfeited or cancelled

 

Outstanding as of March 31, 2018
796

 
$
110.51

Market Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
:
 
 
Market-Based
Restricted  Stock
Units
(in thousands)
 
Weighted-
Average  Grant
Date Fair Value
Outstanding as of March 31, 2017
 
1,282

 
$
87.37

Granted
 
706

 
140.93

Vested
 
(430
)
 
76.27

Forfeited or cancelled
 
(216
)
 
91.88

Outstanding as of March 31, 2018
 
1,342

 
$
118.35